Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aspirin therapy in vernal conjunctivitis.

M B Abelson, S I Butrus, J H Weston

    American Journal of Ophthalmology
    |April 1, 1983
    PubMed
    Summary

    Aspirin therapy significantly improved symptoms in patients with vernal conjunctivitis by inhibiting prostaglandin D2 formation. This suggests oral aspirin may be a valuable adjunctive treatment for severe allergic eye disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Research abstracts presented at the Eastern Allergy Conference, Palm Beach, Florida, May 6-9, 2010.

    Allergy and asthma proceedings·2017
    Same author

    The spiritual dimension in psychosocial assessment: A case study.

    Journal of religion and health·2013
    Same author

    Nucleotide sequence variation in salmonid alphaviruses from outbreaks of salmon pancreas disease and sleeping disease.

    Diseases of aquatic organisms·2005
    Same author

    Circovirus-infected geese studied by in situ hybridization.

    Avian pathology : journal of the W.V.P.A·2005
    Same author

    Detection and antigenic characterization of salmonid alphavirus isolates from sera obtained from farmed Atlantic salmon, Salmo salar L., and farmed rainbow trout, Oncorhynchus mykiss (Walbaum).

    Journal of fish diseases·2004
    Same author

    First isolation of sleeping disease virus from rainbow trout, Oncorhynchus mykiss (Walbaum), in the United Kingdom.

    Journal of fish diseases·2004

    Area of Science:

    • Ophthalmology
    • Allergic Diseases
    • Pharmacology

    Background:

    • Prostaglandin D2 (PGD2) is a key mediator in allergic ocular inflammation, contributing to symptoms like redness and discharge.
    • Current antihistamine treatments offer only symptomatic relief for allergic eye conditions.
    • The role of PGD2 in vernal conjunctivitis suggests potential therapeutic targets beyond histamine.

    Observation:

    • Three patients with severe vernal conjunctivitis were treated with oral aspirin as an adjunct therapy.
    • Aspirin's mechanism involves acetylating cyclooxygenase, thereby inhibiting PGD2 synthesis.
    • Clinical assessments were performed within two weeks of initiating aspirin treatment.

    Findings:

    • Significant reduction in conjunctival and episcleral redness was observed.
    • Resolution of keratitis and limbal infiltration occurred in all treated patients.
    • Rapid and dramatic improvement in ocular inflammation was noted within two weeks.

    Implications:

    • Oral aspirin shows promise as an effective adjunctive therapy for intractable vernal conjunctivitis.
    • Targeting prostaglandin D2 synthesis offers a novel therapeutic strategy for allergic eye diseases.
    • Further research into aspirin's role in managing severe allergic ocular conditions is warranted.

    Related Experiment Videos